"So in laymen's terms, if a treated patient and a placebo patient start the same day and the event of the placebo happens 2 weeks after starting while the event of the treated person happens 4 weeks after starting,... the treated person's event will count as more positive results (which, in my view shuould be).... is that correct,..?"
The primary endpoint of BETonMACE is "Time to first occurrence of adjudication-confirmed narrowly defined MACE." So a longer time period to event for an apabetalone-treated patient compared to a placebo-treated patient would be consistent with apabetalone having a beneficial effect.
BDAZÂ
